|
Complete Genomics Files for IPO; Sequenced About 200 Human Genomes So Far this Year
Complete Genomics plans to raise up to $86.25 million in an initial public offering of its common stock, according to documents filed with the US Securities and Exchange Commission last week.
(Aug 2, 2010)
Complete Genomics plans $86.3M IPO of stock
Complete Genomics Inc. is planning to raise as much as $86.2 million in an initial public offering of stock to help fund improvements and expansion of its DNA sequencing technology.
(Aug 2, 2010)
Complete Genomics Seeks IPO
Complete Genomics, the Mountain View, CA-based company with a new model for inexpensive gene sequencing, has filed a prospectus with the Securities and Exchange Commission to go public. The company hopes to raise as much as $86 million through an IPO that would be underwritten by UBS, Baird, Jefferies & Co., and Cowen & Co. ...
(Aug 2, 2010)
Minnesota Genomics Partnership Soliciting Requests for Research Proposals
NEW YORK (GenomeWeb News) The Minnesota Partnership for Biotechnology and Medical Genomics, a joint research collaboration of the University of Minnesota and Mayo Clinic, is making up to $4 million available in awards to researchers for human health and disease studies that the institutions cannot carry out individually.
(Aug 4, 2010)
Probing proteins
How to make sense of proliferating proteomics data even if youre not a proteomicist
(Aug 4, 2010)
More detailed picture of asthma may yield dramatically improved treatment
Using highly parallel proteomic scans and advanced bioinformatics, researchers have identified distinct asthma subtypes -- information that could lead to far more effective treatments.
(Aug 4, 2010)
Unimas Sets Up First Centre For Sago Research In Region
KOTA SAMARAHAN, Aug 5 (Bernama) -- Universiti Malaysia Sarawak (Unimas) has set up the Centre of Excellence for Research in Sago Palm-CoESAR, which focuses on four main research areas, namely agronomy, molecular genetics, starch technology, and processing and usage of waste from the sago industry.
(Aug 5, 2010)
Summit Exploring The Pioneering Work Of Drug Discovery, September 19-21, 2010, Las Vegas, Nevada
When most of us think of pharmaceutical R&D, our thoughts turn towards human clinical trials. However, there are years of research and thousands of failed attempts before a drug reaches that point. The drug discovery process begins when scientists in academia, research institutions, pharmaceutical and biotechnology companies identify the cellular and genetic factors that play a role in a certain ...
(Aug 5, 2010)
Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine
Irvine, California, and Amsterdam, August 5, 2010 (ots/PRNewswire) - Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, ...
(Aug 5, 2010)
Illumina Files Patent Infringement Suit against Complete Genomics
NEW YORK (GenomeWeb News) Illumina has filed a lawsuit this week against Complete Genomics, alleging infringement of three sequencing-related patents held by Illumina.
(Aug 5, 2010)
WaferGen Launches Breakthrough SmartChip Real-Time PCR System, the Next Generation Real-Time System for Pathway Based ...
FREMONT, Calif., Aug. 5 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced it has launched the breakthrough WaferGen SmartChip Real-Time PCR System, the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform ...
(Aug 5, 2010)
Nuclea opens new Pittsfield genomics center
Nuclea Biotechnologies LLC, a cancer research firm based in Worcester and Pittsfield, opened the Nuclea Genomics Center Wednesday in Pittsfield. The new 3,500-square-foot facility will be used for the companys instrumentation and bioinformatics related to gene expression profiles.
(Aug 5, 2010)
Mali: Country to Rear Malaria-Resistant, Genetically-Modified Mosquitoes
A laboratory in Mali will soon be rearing Africa's first mosquitoes genetically modified to resist malaria.
(Aug 5, 2010)
Illumina Sues Complete Genomics for Infringement; Two Patents in Case Under Reexamination with USPTO
Illumina and its predecessor Solexa sued Complete Genomics this week, alleging that the human genome sequencing service provider infringes three of Illuminas patents.
(Aug 5, 2010)
Genetic Clue To Chronic Pain Could Lead To New Treatments For The Condition
Chronic pain is a serious medical problem, afflicting approximately 20% of adults. Some individuals are more susceptible than others, and the basis for this remains largely unknown. In a report published online today in Genome Research (http://www.genome.org), researchers have identified a gene associated with susceptibility to chronic pain in humans, signaling a ...
(Aug 5, 2010)
Hebrew University Researchers Identify Gene Related To Chronic Pain
Researchers at the Hebrew University of Jerusalem and elsewhere have succeeded in identifying for the first time a gene associated with susceptibility to chronic pain caused by nerve injury in humans, signaling a significant step toward better understanding and treating of the condition.Chronic pain is a serious medical problem, afflicting approximately 20% of adults. Some individuals are more ...
(Aug 5, 2010)
WaferGen launches SmartChip System for discovery, validation of biomarkers
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced it has launched the breakthrough WaferGen SmartChip Real-Time PCR System, the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform. The SmartChip System is designed to provide accurate, highly sensitive and high ...
(Aug 5, 2010)
Agendia inaugurates new clinical genomics laboratory
Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington Beach, CA. The new laboratory will further increase capacity to support Agendia's strong commercial expansion in the U.S. market, as well as the use of multiple ...
(Aug 5, 2010)
Akonni Biosystems receives patent for TruTip Extraction Kits
Akonni Biosystems, a developer of low-cost, multiplex molecular diagnostic testing systems, today announced that the United States Patent and Trademark Office issued a patent on July 20, 2010 for its method for rapidly purifying nucleic acids. U.S. Patent No. 7,759,112 entitled, "Apparatus, system, and method for purifying nucleic acids" protects the Company's use of its pioneering nucleic acid ...
(Aug 5, 2010)
Scientists identify genetic variant that increases risk of schizophrenia
A group of scientists has identified a genetic variant that substantially increases the risk for developing schizophrenia in Ashkenazi Jewish and other populations. The study, published by Cell Press on August 5th in the American Journal of Human Genetics, associates a deletion on chromosome 3 with increased incidence of schizophrenia.
(Aug 5, 2010)
Gene related to chronic pain discovered
Washington, August 06 : Researchers at the Hebrew University of Jerusalem have found a gene, which is linked with susceptibility to chronic pain caused by nerve injury in humans.
(Aug 6, 2010)
BioWatch: FDA gives blessing to Baltimore company's diabetes system
A Baltimore company has won a key federal regulatory approval for its diabetes management software system, which it plans to start marketing early next year.
(Aug 6, 2010)
Potential New Treatments For Chronic Pain Offered By Genetic Clue
Chronic pain is a serious medical problem, afflicting approximately 20% of adults. Some individuals are more susceptible than others, and the basis for this remains largely unknown. In a report published online in Genome Research, researchers have identified a gene associated with susceptibility to chronic pain in humans, signaling a significant step toward better understanding and treating the ...
(Aug 6, 2010)
DJ press1.de/Progress in Data Mining - Report about the.
Progress in Data Mining -Report about the Industrial Conference on Data Mining, ICDM 2010 The 10th Industrial Conference on Data Mining ICDM 2010 held in July in Berlin showed once more that the event is a must for all data miners from research and industry alike who like to stay informed about hot new topics in data mining.
(Aug 6, 2010)
Stellar Pharmaceuticals Reports Second Quarter 2010 Financial Results
LONDON, ONTARIO--(Marketwire - 08/06/10) - Stellar Pharmaceuticals Inc. (OTC.BB: SLXCF - News ) ("Stellar" or "the Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced financial results for the quarter ended June 30, 2010. In this press release, all dollar amounts are expressed in Canadian currency ...
(Aug 6, 2010)
Von Eschenbach Joins Focused Ultrasound Surgery Foundation Board
Andrew von Eschenbach, M.D., a thought leader and healthcare visionary of international stature, has become the newest member of the Focused Ultrasound Surgery Foundation's Board of Directors. Elected at the Board's August 4 meeting, von Eschenbach has the distinction of being the only person to have led both the U.S. Food and Drug Administration and the National Cancer Institute at the National ...
(Aug 6, 2010)
New Earth BioMed Launches Natural-Product-Based Cancer Drug Discovery Program
New Earth BioMed, a new 501(c)3 nonprofit corporation, has launched a long-term drug discovery program to identify mixtures of nontoxic plant compounds useful in treating cancer. An estimated 77 percent of approved cancer and anti-infective drugs in the United States are either natural products or are derived from them. Of the tens of thousands of bioactive natural products that exist, New Earth ...
(Aug 6, 2010)
A First: Hebrew University, International Researchers, Identify A Gene Affecting Chronic Pain, Opens Way For New ...
Researchers at the Hebrew University of Jerusalem and elsewhere have succeeded in identifying for the first time a gene associated with susceptibility to chronic pain caused by nerve injury in humans, signalling a significant step toward better understanding and treating of the condition. Chronic pain is a serious medical problem, afflicting approximately 20% of adults. Some individuals are more ...
(Aug 6, 2010)
Woman of science
The trailblazing molecular geneticist is dedicated to answering life's big questions and giving others the same opportunities.
(Aug 6, 2010)
Bad And Harmful Bacteria Share, Swap Genes
The genetic make-up of pathogenic bacteria and their harmless cousins is much more similar than previously thought, UA microbiologists find.In the bacterial world, good guys can potentially turn into bad guys and vice versa - just by swapping genes, microbiologists at the University of Arizona have discovered.The researchers studied bacteria belonging to the genus Neisseria. These bacteria ...
(Aug 6, 2010)
Spanish Team Develops Tool to Help Researchers Stay on Top of the Bioinformatics 'Resourceome'
Researchers at the Polytechnic University of Madrid have developed a tool that can discover and automatically classify bioinformatics resources from the scientific literature and have used it to compile a searchable index of software and databases.
(Aug 6, 2010)
Merck Uses Phosphoproteomics to Identify Potential Biomarkers for Cancer Drug Development
A research team led by Merck scientists has taken what could represent a first step toward using phosphoproteins as biomarkers for cancer drug development.
(Aug 6, 2010)
Von Eschenbach Joins Focused Ultrasound Surgery Foundation Board
Former head of FDA and National Cancer Institute, Andrew von Eschenbach, joins board of Focused Ultrasound Surgery Foundation
(Aug 6, 2010)
Research and Markets: This Latest Proteomics - Technologies, Markets and Companies Report is Now Available
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.co has announced the addition of Jain PharmaBiotech's new report "Proteomics - Technologies, Markets and Companies" to their offering. This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular ...
(Aug 6, 2010)
Newly discovered mechanism controls levels and efficacy of a marijuana-like substance in the brain
A newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana, but that is produced by the body's own nerve cells.
(Aug 6, 2010)
QCMG Selects SGI Solution for ICGC Project
The Queensland Centre for Medical Genomics (QCMG) at the University of Queensland has selected SGI's LiveArc storage solution to aid with its storage and processing needs for human cancer genome sequence data.
(Aug 6, 2010)
Von Eschenbach Joins Focused Ultrasound Surgery Foundation Board
Former head of FDA and National Cancer Institute, Andrew von Eschenbach, joins board of Focused Ultrasound Surgery Foundation CHARLOTTESVILLE, Va., Aug. 6 /PRNewswire-USNewswire/ -- Andrew von Eschenbach, M.D., a thought leader and healthcare visionary of international stature, has become the newest member of the Focused Ultrasound Surgery Foundation's Board of Directors. Elected at the Board's ...
(Aug 6, 2010)
Bats facing regional extinction in Northeastern US from rapidly spreading white-nose syndrome
A new infectious disease spreading rapidly across the northeastern United States has killed millions of bats and is predicted to cause regional extinction of a once-common bat species, according to new findings. Estimates show over 99 percent of Northeast's little brown bat population may become extirpated in 20 years due to white-nose syndrome.
(Aug 6, 2010)
SQI to Raise Up to $4.9M in Private Placement
NEW YORK (GenomeWeb News) SQI Diagnostics today announced it plans to raise up to C$5 million ($4.9 million) through a non-brokered private placement.
(Aug 6, 2010)
Von Eschenbach Joins Focused Ultrasound Surgery Foundation Board
Former head of FDA and National Cancer Institute, Andrew von Eschenbach, joins board of Focused Ultr...
(Aug 6, 2010)
Hybrigenics' H1 Revenues from Proteomics Services Rise; Overall Revenues Decline
French biotech company Hybrigenics announced this week that revenues from its proteomics services division rose 4 percent year-over-year in the first half of 2010.
(Aug 6, 2010)
Bats facing regional extinction from rapidly spreading disease
A new infectious disease spreading rapidly across the northeastern United States has killed millions of bats and is predicted to cause regional extinction of a once-common bat species, according to the findings of a University of California, Santa Cruz researcher.
(Aug 6, 2010)
Newly discovered mechanism controls levels and efficacy of a marijuana-like substance in the brain
A newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana, but that is produced by the body's own nerve cells. Cannabinoid signaling systems are common throughout the body and affect a variety of functions. Developing new therapies that modulate these molecular communications might help patients with autoimmune ...
(Aug 6, 2010)
BioSpain 2010 to Showcase International Biotechnology Sector
MADRID, August 6, 2010 /PRNewswire/ -- The Spanish Bioindustry Association (ASEBIO), in collaboration with the Navarre Society of Development (SODENA), and the government of Navarre, will host BioSpain 2010 (http://www.biospain.org), the biennial international gathering of experts in the biotechnology sector, in Pamplona from September 29th to October 1st. BioSpain ...
(Aug 6, 2010)
BCF publishes two new patient publications on Pain Management and Physical Therapy
The Bone and Cancer Foundation (BCF) is announcing the publishing of two new patient publications on Pain Management and Physical Therapy and other Rehabilitation Therapies. Other publication topics include: Breast Cancer, Prostate Cancer, Lung Cancer, Osteonecrosis of the Jaw, Vitamin D, Surgery, Myeloma and Osteosarcoma.
(Aug 6, 2010)
Studying Bias, MAQC-II Finds Multiple Factors May Affect Array-Based Predictions
Array batch sizes , data-analysis methods, and the experience of researchers conducting those analyses all can introduce bias into experiments that use microarray technology to predict disease, drug response, and drug toxicity, according to a number of recent studies.
(Aug 7, 2010)
Cancer News: U.S. Cancer Rates Steadily Declining
Dr. George Hollenberg, founding director of Acupath Laboratories, Inc., a cancer genetics and specialty medical lab in New York, on improved diagnostics across all cancers and on specific tips for prostate cancer detection
(Aug 8, 2010)
New study by UCSC researcher predicts regional extinction of the common little brown bat
SANTA CRUZ -- A study by UCSC environmental studies researcher Winifred F. Frick predicts a regional extinction in the northeastern U.
(Aug 8, 2010)
Life Technologies, UCSD partner to use SOLiD 4 genomic analysis technology in research programme to study CLL
Life Technologies Corporation and the University of California at San Diego (UCSD) Moores Cancer Center announced a partnership to use SOLiD 4 genomic analysis technology in a research programme to study chronic lymphocytic leukaemia (CLL), a cancer of the white blood cells.
(Aug 8, 2010)
TASC, Inc. Appoints Rashid Chotani to Lead Chemical-Biological Defense Programs
CHANTILLY, Va. | Rashid Chotani, M.D., M.P.H., has joined TASC, Inc. as director of Chemical-Biological Defense Programs. In this role, Chotani will lead chemical and biological programs that...
(Aug 9, 2010)
|
